Ernst Gleichmann - Concepedia

Author

Ernst Gleichmann

Heinrich Heine University Düsseldorf

Also Known As

E GLEICHMANN, E Gleichmann, E. GLEICHMANN, E. Gleichmann, Ernst Gleichmann, Ernst Gleichmann, M.D.

168

Publications

6.1K

Citations

H-Index

116

Concepts

All Affiliations

Heinrich Heine University Düsseldorf Dutch Blood Transfusion Society Institute of Medical Microbiology and Hygiene University of Amsterdam

About

Ernst Gleichmann is an author at Heinrich Heine University Düsseldorf specializing in medicine, immunology, and autoimmunity.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	32	54	2.9K
2	Allergy	19	25	1.2K
3	Allergy Medicine	3	3	136
4	Health Sciences	2	2	91
5	Public Health	2	2	103

Ernst Gleichmann

Publications

4.7K

Citations

H-Index

Page 1

	Year	Citations
Graft-versus-host reactions: clues to the etiopathology of a spectrum of immunological diseases Ernst Gleichmann, Steven T. Pals, A G Rolink, Immunology Today InflammationTransplantationAutoimmune DiseaseGraft-versus-host ReactionsPathogenesis	1984	346
A systemic lupus erythematosus (SLE)‐like disease in mice induced by abnormal T‐B cell cooperation. Preferential formation of autoantibodies characteristic of SLE Ernst Gleichmann, E H van Elven, J.P.W. van der Veen European Journal of Immunology Clinical ImmunologyImmunohematologyImmunodeficienciesImmunologyPathology	1982	276
IL-4 is required for the IgE and IgG1 increase and IgG1 autoantibody formation in mice treated with mercuric chloride M Ochel, H.-W. Vohr, Christiane Pfeiffer, The Journal of Immunology	1991	156
Allosuppressor- and allohelper-T cells in acute and chronic graft-vs.-host (GVH) disease. III. Different Lyt subsets of donor T cells induce different pathological syndromes. A G Rolink, Ernst Gleichmann The Journal of Experimental Medicine ImmunologyDifferent Lyt SubsetsPathologyDonor T CellsImmunotherapy	1983	129
Allosuppressor and allohelper T cells in acute and chronic graft-vs.-host disease. II. F1 recipients carrying mutations at H-2K and/or I-A. A G Rolink, Steven T. Pals, Ernst Gleichmann The Journal of Experimental Medicine HistocompatibilityClass IiCell TherapyF1 RecipientsImmunology	1983	114
CHRONIC ALLOGENEIC DISEASE Martine Y. K. Armstrong, Ernst Gleichmann, Helga Gleichmann, The Journal of Experimental Medicine Chronic Allogeneic DiseaseImmunologyImmunoeditingPathologyImmunotherapy	1970	113
Mercuric chloride induces autoantibodies against U3 small nuclear ribonucleoprotein in susceptible mice. R. Reuter, Gabriela Tessars, H.-W. Vohr, Proceedings of the National Academy of Sciences Autoimmune DiseaseSclerodermaAllergyScleroderma PatientsMedicine	1989	112
Adverse immune reactions to gold. I. Chronic treatment with an Au(I) drug sensitizes mouse T cells not to Au(I), but to Au(III) and induces autoantibody formation. D Schuhmann, Malgorzata Kubicka-Muranyi, J Mirtschewa, The Journal of Immunology	1990	103
Immunological alterations inducible by mercury compounds. III. H‐2A acts as an immune response and H‐2E as an immune “suppression” locus for HgCl<sub>2</sub>‐induced antinucleolar autoantibodies Jasmina Mirtcheva, Christiane Pfeiffer, Jan A. Bruijn, European Journal of Immunology	1989	89
Immunological alterations inducible by mercury compounds. II. HgCl2 and gold sodium thiomalate enhance serum IgE and IgG concentrations in susceptible mouse strains. P Pietsch, H.-W. Vohr, Klaus Degitz, PubMed Clinical ImmunologyLaboratory ImmunologyImmunologyImmune RegulationPathology	1989	85

Page 1